Maria-Luisa Maccecchini
Dr. Maria-Luisa Maccecchini is a President, Chief Executive Officer & Director at Annovis Bio, Inc. and an Independent Director at Treventis Corp. She is on the Board of Directors at Annovis Bio, Inc. and Treventis Corp. Dr. Maccecchini was previously employed as a Chief Executive Officer by Annovis, Inc., a General Manager by Bachem Bioscience, Inc., a Head-Molecular Biology by Mallinckrodt LLC, a Head-Molecular Biology by Mallinckrodt, Inc.(Old), a Chief Executive Officer by Message Pharmaceuticals, Inc., a Director & Partner by Mid-Atlantic Angel Group, and a Member by Robin Hood Ventures. She also served on the board at Protez Pharmaceuticals, Inc. She received her doctorate degree from The Rockefeller University.
Transactions
Date
Transaction
Value
| 01/14/2022 | 32,959 | Derivative/Non-derivative trans. at $0.14 per share. | 4,614 |
| 12/20/2021 | 20,000 | Gift at $0 per share. | 0 |
| 10/11/2021 | 18,000 | Acquisition at $27.61 per share. | 496,980 |
| 07/01/2021 | 1,000 | Gift at $0 per share. | 0 |
| 07/01/2021 | 1,000 | Gift at $0 per share. | 0 |
| 07/15/2020 | 10,000 | Gift at $0 per share. | 0 |
| 04/27/2020 | 10,000 | Gift at $0 per share. | 0 |
| 01/31/2020 | 762,896 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/31/2020 | 7,937 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/31/2020 | 1,600 | Acquisition at $6 per share. | 9,600 |
